News Releases

Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.

Get News Alerts by Email

Jun 19, 2018

Astellas Employees at National Sales Forum Support Five Anaheim-Area Non-Profits

Employees Also Raised More Than $55,000 at Third Annual "One Astellas Spirit Run" for Seven Charitable Organizations
- Video 1
- Photos 2
Jun 8, 2018

Astellas names Nahrin Marino to Vice President, Head of Ethics & Compliance Americas
- Photos 1
Jun 3, 2018

Astellas and Seattle Genetics Present at ASCO 2018 on Enfortumab Vedotin in Patients with Locally Advanced or Metastatic Urothelial Cancer Previously Treated with Checkpoint Inhibitor Therapy

-Updated Data from Phase 1 EV-101 Study Highlighted in ASCO 2018 Oral Presentation Support Rapid Development Program and Ongoing Pivotal Study-
May 31, 2018

Astellas Oncology C3 Prize® Returns for Third Year with Focus on Improving Cancer Care in Underserved Regions of the World

2018 Challenge Will Award a Total of $100,000 in New Grants to Help Reduce the Unequal Burden of Cancer
May 29, 2018

U.S. FDA Grants Priority Review to Astellas' New Drug Application for Gilteritinib for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
May 16, 2018

Astellas Announces Abstracts Highlighting Growing Oncology Portfolio to be Presented at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 15, 2018

Astellas Appoints Bernhardt Zeiher, M.D., as New Chief Medical Officer

Joins Company's Executive Leadership Team
- Photos 1
May 7, 2018

FDA Approves Supplemental New Drug Application for Myrbetriq® (mirabegron) for Use in Combination with solifenacin succinate for the Treatment of Overactive Bladder Symptoms
May 2, 2018

Astellas Included in Forbes Best Midsize Employers List for Fourth Year
Apr 30, 2018

Astellas' Nahrin Marino named a 2018 Healthcare Businesswomen's Association Luminary
- Photos 1

Show per page